Skip to content

King Pharmaceuticals KG Legacy Reinsurance — Net premiums earned

Other segment segments

AmTrust Legacy Segment
$2.29M
Diversified Legacy Segment
$867K

Similar metrics at other companies

Everest Group logo
EGLegacy — Net written premiums
$89M-83.9%
Everest Group logo
EGLegacy — Premiums earned
$399M-26.1%
Everest Group logo
EGLegacy — Premiums Written, Gross
$135M-80.3%
ESN
ESNTReinsurance — Net premiums earned
$29.31M+86.3%
Axis Capital Holders logo
AXSReinsurance — Net premiums earned
$338.71M+2.4%
SiriusPoint logo
SPNTReinsurance — Net premiums earned
$277.48M+6.2%

Other financials

Income statement

See full
Revenue$10.2M+1,112%
Net income-$7.4M-1,786%
EPS (diluted)-$0.96-586%

Balance sheet

See full
Cash & equivalents$62.2M+1,724%
Total debt$176.7M
Total equity$121.4M+2,773%
Total assets$964.2M

Cash flow

See full
Operating cash flow-$15.1M-1,628%

Valuation

See full
Market cap$70.42M-71.3%
Enterprise value$184.93M-52.3%
P/E1.2×
P/S1.6×-27.7×

Profitability

See full
Net margin131.5%

Returns & leverage

See full
Return on equity90.8%
Debt / equity1.5×

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PremiumsEarnedNet.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's legacy reinsurance — net premiums earned.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is King Pharmaceuticals's legacy reinsurance — net premiums earned?
King Pharmaceuticals (KG) reported legacy reinsurance — net premiums earned of $3.16M in Q1 2026.
What does legacy reinsurance — net premiums earned mean?
Reflects the portion of net premiums written that is recognized as revenue over the policy period. It serves as the primary revenue driver for the underwriting operations of the legacy reinsurance segment.